FANCD2 and cancer: As a first step in testing this hypothesis, we carried out a pilot study to analyze the expression of five proteins (Ki-67, Cyclin E, POLD3, γH2AX and FANCD2) on a collection of 32 tumor samples from a representative range of cancer types (colon, lung, breast or stomach).